Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Canada OKs Pfizer COVID-19 Booster For Kids Aged 5-11 Years
Yahoo/Benzinga
Mon, 08/22/22 - 09:47 am
Tags:
Canada, Pfizer, BioNTech, COVID-19, vaccines, pediatric, boosters
Pfizer discontinues development of dilated cardiomyopathy drug emprumapimod
Clinical Trials Arena
Thu, 08/18/22 - 11:14 pm
Tags:
Pfizer, dilated cardiomyopathy, clinical trials, emprumapimod
With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2
Fierce Pharma
Mon, 08/15/22 - 10:35 am
Tags:
earnings, Pfizer, AstraZeneca, Merck, Big Pharma, inflation, supply chain, Ukraine, pandemic, COVID-19
Pfizer CEO Bourla shows mild symptoms after testing positive for COVID
Reuters
Mon, 08/15/22 - 10:31 am
Tags:
Pfizer, Albert Bourla, Pharma CEOs, COVID-19, vaccines
Pfizer's 20-valent pneumococcal vaccine hits goal in infant trial, teeing up 2022 approval filing
Fierce Biotech
Fri, 08/12/22 - 10:16 am
Tags:
Pfizer, vaccines, Prevnar 20, FDA, infants, clinical trials, pneumococcal disease
In warranty program, Pfizer will refund up to $50K for patients who discontinue use of rare disease drug
Fierce Pharma
Wed, 08/10/22 - 12:04 am
Tags:
Pfizer, Xalkori, warranty, Panzyga, CIPD
Workers at Pfizer Australian manufacturing site the latest to walk out in labor dispute protests
Endpoints
Tue, 08/9/22 - 11:52 pm
Tags:
Pfizer, Australia, labor disputes
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
BioSpace
Tue, 08/9/22 - 06:27 am
Tags:
Pfizer, Valneva, clinical trials, vaccines, Lyme disease, VLA15
Pfizer and Myovant’s endometriosis pain drug Myfembree gets another FDA nod
Endpoints
Mon, 08/8/22 - 11:28 pm
Tags:
Pfizer, Myovant, FDA, Myfembree, endometriosis
Pfizer buys sickle cell drugmaker Global Blood for $5.4B
BioPharma Dive
Mon, 08/8/22 - 10:29 am
Tags:
Pfizer, Global Blood Therapeutics, M&A, sickle cell disease, Oxbryta
Pfizer, riding high on COVID windfall, eyes $5B play for Global Blood Therapeutics
Fierce Pharma
Sun, 08/7/22 - 11:27 pm
Tags:
Pfizer, Global Blood Therapeutics, M&A, Oxbryta
Alnylam drug succeeds in heart study, setting stage for FDA filing and showdown with Pfizer
MedCity News
Thu, 08/4/22 - 11:09 am
Tags:
Alnylam, Pfizer, Onpattro, hATTR
Pfizer to discontinue Phase III dilated cardiomyopathy trial
Clinical Trials Arena
Thu, 08/4/22 - 10:58 am
Tags:
Pfizer, clinical trials, dilated cardiomyopathy, PF-07265803
July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
Tags:
layoffs, hirings, Astellas, Pfizer, Eikon Therapeutics, Bayer, Avadel Pharma, Heron Therapeutics, Adverum Biotechnologies, Biogen, Eisai, X4 Pharmaceuticals, Assembly Biosciences
Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data
Fierce Pharma
Tue, 08/2/22 - 10:54 am
Tags:
Roche, Pfizer, Merck, Tecentriq, clinical trials, cancer, checkpoint inhibitors
Why Pfizer and BioNTech Are Beating Moderna in the Omicron Booster Market
Motley Fool
Tue, 08/2/22 - 10:32 am
Tags:
Pfizer, BioNTech, Moderna Therapeutics, vaccines, COVID-19, boosters, government contract
Pfizer sales of COVID-19 vaccine, pill beat forecasts as company prepares for future waves
BioPharma Dive
Thu, 07/28/22 - 12:27 pm
Tags:
Pfizer, earnings, Paxlovid, vaccines, COVID-19
The NASH curse strikes again. Pfizer dumps early-stage asset for liver condition
Fierce Biotech
Thu, 07/28/22 - 11:08 am
Tags:
Pfizer, PF-06882961, NASH
Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits
BioSpace
Wed, 07/27/22 - 10:47 am
Tags:
Pfizer, BioNTech, COVID-19, vaccines, boosters, patents, CureVac
Pfizer loses court battle to keep its Vyndaqel copay assistance for Medicare patients—again
Fierce Pharma
Tue, 07/26/22 - 05:23 pm
Tags:
Pfizer, copay asssistance programs, Vyndaqel, Medicare, kickbacks

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.